According to the most recent financial data from December 2025, the EPS for the trailing twelve months is $2.92. Icon's EPS for 2025 amounted to $2.92, marking a drop from $8.96 in 2024. During the quarterly period ending on Dec 31, 2025, ICLR's EPS stood at $1.95.
Icon had an annual EPS of $2.92, indicating a drop of 67.4% from $8.96 in 2024. The quarterly per-share earnings for the period ending Dec 31, 2025, was $1.95, indicating a 45.8% decrease from the same quarter last year. ICLR's 12-month EPS stands at $2.92 as of December 2025. Icon's annual EPS in 2024 stood at $8.96, a 32.7% increase year-over-year.
Icon has registered a decrease in EPS of 45.8% during the last 12 months (YoY, quarterly). Examining a broader timeline, the company maintained an average EPS growth rate of -22.2% per year for the last three years. Icon had an average annual EPS growth rate of -14% during the last 5 years. A 10-year view shows that ICLR has seen an average EPS growth of -3.3% per year.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| ICLR Icon Plc | 52.32 | -67.4% | -22.2% | -14% |
| CRL Charles River Laboratories International Inc | N/A | -1,555% | N/A | N/A |
| SCYX Scynexis Inc | N/A | 61.4% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.